At Biocomposites, we are pioneering calcium compound devices to regenerate and repair bone and soft tissue. With over 25 years’ experience of manipulating the surface chemistry and crystalline properties of calcium compounds, we engineer and manufacture products at the forefront of calcium technology.

With a singular focus on developing innovative calcium compound medical devices, Biocomposites has gained a deep expertise in musculoskeletal infections, trauma, spine and sports injuries. Connected with universities and hospitals around the world, Biocomposites continues to innovate in infection management to support surgeons and their patients.

Possessing unique characteristics for regenerating bone and managing dead space, our products are opening new possibilities for surgeons around the world in trauma, spine, sports injuries and musculoskeletal infections – one of the biggest healthcare challenges of the 21st century.

Type
Private
HQ
Keele, GB
Size (employees)
83 (est)+21%
Biocomposites is headquartered in Keele, GB
Report incorrect company information

Biocomposites Office Locations

Biocomposites has an office in Keele
Keele, GB (HQ)
Science Park University of Keele
Show all (1)
Report incorrect company information

Biocomposites Financials and Metrics

Summary Metrics

Time since last funding

a year ago
Show all financial metrics

Biocomposites Financials

Biocomposites's revenue was reported to be £22.15 m in FY, 2016
GBP

Revenue (FY, 2016)

22.1 m

Net income (FY, 2016)

11.7 m

EBITDA (FY, 2016)

13.4 m

EBIT (FY, 2016)

13.2 m

Cash (31-Dec-2016)

15.4 m
GBPFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

9 m10.3 m15.7 m22.1 m

Revenue growth, %

15%52%

Operating expense total

7.6 m7.9 m8.9 m

EBITDA

2.8 m8 m13.4 m
GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Cash

1.6 m904.9 k62.5 k1.6 m790.2 k1.5 k3.1 m4.5 m8.6 m15.4 m

Accounts Receivable

825.7 k476 k315.2 k1.3 m1.4 m1.6 k373 k448 k660 k646 k

Inventories

348.1 k732.6 k470.1 k383 k399.8 k393 641 k451 k975 k796 k

Current Assets

2.8 m2.1 m847.9 k3.2 m2.6 m3.7 k6.5 m8.5 m14.8 m22.8 m
GBPFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

2.5 m7.3 m11.7 m

Income Taxes Paid

(728 k)(169 k)(585 k)
GBPY, 2016

Revenue/Employee

293.7 k

Financial Leverage

1.1 x
Show all financial metrics
Report incorrect company information

Biocomposites News and Updates

Bio Absorbable Implants Market Show Exponential Growth by 2025

The bio-absorbable implant is chemical compounds which are designed to be absorbed by the body without eliciting the immune response. Posted via Industry Today. Follow us on Twitter @IndustryToday

Global Tissue Engineering Market 2017 Industry Key Players, Share, Trend, Applications, Segmentation and Forecast to 2022

Wiseguyreports.Com adds “Tissue Engineering Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2022” To Its Research Database. Posted via Industry Today. Follow us on Twitter @IndustryToday

Green Composites Global Market 2017 Key Players,Share, Trend, Segmentation And Forecast To 2022

Market Analysis Research Report On “Global Green Composites Market 2017 Industry Growth, Size, Trends, Share, Opportunities And Forecast To 2022” To Their Research Database. Posted via Industry Today. Follow us on Twitter @IndustryToday

Biocomposites pulls in funding from TA Associates

TA Associates has made an undisclosed investment in UK-based Biocomposites, a maker of calcium compound biologics. Barings provided senior loans to back the transaction. No financial terms were disclosed.
Report incorrect company information